1. Generics Bulletin
  2. >>Leadership

Canada’s CGPA Installs New Leaders

Appoints New Chair And Vice-Chair From Pharmascience And Apotex

 
• By Dave Wallace

Canada’s off-patent industry association has looked to Pharmascience and Apotex for its new chair and vice-chair.

Canada leader flag speech
Canada’s CGPA has a new chair • Source: Shutterstock

Pharmascience chief operating officer Jean-Guy Goulet and Apotex commercial vice-president for Canada and the Caribbean, Ray Shelley, have been respectively named as the new chair and vice-chair of the Canadian Generic Pharmaceutical Association. Both were unanimously elected to their new positions.

Goulet – who joined Pharmascience in 2017, having previously held senior management positions at Ratiopharm, Watson and Actavis – was elected to the position of chair after having previously served as vice-chair of the CGPA

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance

 
• By Dave Wallace

Aeon Biopharma has picked up Revance Therapeutics executive Rob Bancroft to serve as its new CEO as it continues to pursue a biosimilar version of Botox. Meanwhile, Coherus has lost its chief commercial officer, as Viatris, Sandoz and Medicines for Ireland have announced new appointments.

Samsung Bioepis Reevaluating Approach To Biosimilars

 
• By Jessica Merrill

The challenging US biosimilar market remains a persistent problem, leading the biosimilar developer to reconsider how it invests in the future while pushing for changes.

Cardinal Looks Ahead To A New Decade For US Biosimilars

 
• By Dave Wallace

In the wake of a report marking 10 years since the first US biosimilar launch, Cardinal Health’s Dracey Poore speaks to Generics Bulletin about the successes seen so far and the obstacles that must be overcome if the market is to thrive in the decade ahead.

Who’s Hired? Alvotech Appoints Strategy And Quality Chiefs

 
• By Dave Wallace

Alvotech has named two new key executives, while Biosimilars Canada has elected its 2025 leaders and the AAM has welcomed the new FDA commissioner in the US.

More from Generics Bulletin